We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAHW
1101
CALL
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
$5.67M 0.01%
565,553
BHACW
1102
CALL
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$5.66M 0.01%
561,102
TECK icon
1103
Teck Resources
TECK
$29.3B
$5.64M 0.01%
149,091
-256,155
-63% -$8.87M
LITE icon
1104
Lumentum
LITE
$55.4B
$5.62M 0.01%
107,819
-98,759
-48% -$6.07M
SJNK icon
1105
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.88B
$5.62M 0.01%
+232,035
New +$5.64M
DKNG icon
1106
DraftKings
DKNG
$12B
$5.59M 0.01%
+490,564
New +$6.83M
IXAQW
1107
CALL
DELISTED
IX Acquisition Corp. Warrant
IXAQW
$5.57M 0.01%
550,542
FRON
1108
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$5.55M 0.01%
550,114
ROIVW
1109
CALL
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$5.54M 0.01%
693,387
TGAA
1110
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
$5.54M 0.01%
540,792
STZ icon
1111
CALL
Constellation Brands
STZ
$22.2B
$5.52M 0.01%
+23,800
New +$5.7M
ALOR
1112
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$5.5M 0.01%
537,206
PTOCW
1113
CALL
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$5.49M 0.01%
543,686
TRAQ.WS
1114
CALL
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$5.48M 0.01%
532,456
GDX icon
1115
VanEck Gold Miners ETF
GDX
$23.2B
$5.47M 0.01%
190,999
-333,259
-64% -$8.91M
CMCA
1116
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
$5.47M 0.01%
529,603
RF icon
1117
Regions Financial
RF
$26.2B
$5.45M 0.01%
252,713
-171,252
-40% -$3.71M
AMR icon
1118
Alpha Metallurgical Resources
AMR
$1.85B
$5.45M 0.01%
37,210
+33,539
+914% +$5.29M
IBER
1119
DELISTED
Ibere Pharmaceuticals
IBER
$5.45M 0.01%
539,807
VRN
1120
DELISTED
Veren
VRN
$5.44M 0.01%
760,867
-799,366
-51% -$5.93M
GTHX
1121
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$5.4M 0.01%
994,988
+362,810
+57% +$3.04M
KCGI
1122
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$5.38M 0.01%
527,185
NVAC
1123
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
$5.37M 0.01%
529,671
STET.WS
1124
CALL
DELISTED
ST Energy Transition I Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, included as part of the SAIL securities
STET.WS
$5.37M 0.01%
524,998
RXDX
1125
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$5.37M 0.01%
+48,777
New +$3.16M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.